https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/730095 Thu, 02 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730095-ernexa-eyes-clinic-with-erna-101-for-ovarian-cancer http://www.bioworld.com/articles/729898 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729898-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729788 Thu, 19 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729788-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729560 Wed, 18 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729560-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729645 Mon, 16 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729645-unixell-biotechs-ux-gip001-gains-ind-clearance-for-epilepsy Brain and encephalography http://www.bioworld.com/articles/729586 Tue, 10 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729586-japan-approves-first-ipsc-therapy-for-parkinsons-disease Induced pluripotent stem cells http://www.bioworld.com/articles/729509 Tue, 10 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729509-c-further-unveils-pediatric-cancer-programs Pipet, test tubes, chemical structures http://www.bioworld.com/articles/729416 Mon, 09 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729416-newcelx-partners-with-eledon-to-advance-ncel-101 Diagram of how cells take up glucose from the stomach and insulin from the pancreas http://www.bioworld.com/articles/729360 Fri, 06 Mar 2026 12:00:00 -0500 https://www.bioworld.com/articles/729360-japan-approves-first-ipsc-therapy-for-parkinsons-disease Induced pluripotent stem cells http://www.bioworld.com/articles/729300 Wed, 04 Mar 2026 12:00:00 -0500 https://www.bioworld.com/articles/729300-fdas-rare-disease-toolbox-not-fully-used Magnifying glass, clock and capsules http://www.bioworld.com/articles/729151 Tue, 03 Mar 2026 08:00:00 -0500 https://www.bioworld.com/articles/729151-sanaregen-visions-svt-001-cleared-for-clinic-for-familial-drusen Medical vector illustration showing cross section of an eyeball with close up of the macula http://www.bioworld.com/articles/729130 Mon, 02 Mar 2026 08:00:00 -0500 https://www.bioworld.com/articles/729130-hitting-solid-tumors-with-a-closer-look-and-a-stronger-car-t-cell CAR T cell attacking cancer cells Illustration of CAR T cell attacking cancer cells. Credit: La Jolla Institute http://www.bioworld.com/articles/729195 Tue, 24 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729195-us-fed-circuit-protects-101-passage-for-some-gene-therapy-patents Patent gears http://www.bioworld.com/articles/729194 Tue, 24 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729194-innovacells-91m-tokyo-ipo-to-fund-incontinence-cell-therapies Glass yen/yuan symbol http://www.bioworld.com/articles/729193 Tue, 24 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729193-astellas-and-vir-in-13b-deal-for-cd3-t-cell-engager Astellas global HQ in Tokyo Astellas global headquarters in Tokyo. Credit: Astellas Pharma Inc. http://www.bioworld.com/articles/729192 Tue, 24 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729192-bladder-phase-ii-sinks-protara-lms-phase-iii-wins-for-palvella Green arrow up red arrow down http://www.bioworld.com/articles/729235 Tue, 24 Feb 2026 11:00:00 -0500 https://www.bioworld.com/articles/729235-japan-endorses-two-ipsc-drugs-for-approval-under-cea-pathway Stem cells http://www.bioworld.com/articles/729179 Mon, 23 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729179-gilead-brings-arcellx-fully-under-the-fold-for-78b Acquisition puzzle http://www.bioworld.com/articles/728971 Mon, 23 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728971-zellunas-zi-ma4-1-gains-uk-cta-clearance-for-solid-tumors T cells http://www.bioworld.com/articles/729099 Fri, 20 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729099-japan-endorses-two-ipsc-drugs-for-approval-under-cea-pathway Stem cells http://www.bioworld.com/articles/728920 Wed, 18 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728920-financing-at-gelmedix-supports-gmx-101-for-geographic-atrophy Dollar sign droplet above test tube N-methyl-D-aspartate receptor (NMDAR) encephalitis, a rare, neuronal antibody-mediated disorder characterized by neuropsychiatric symptoms and impaired cognitive function. hUC-MSCs have previously shown immunomodulatory and anti-inflammatory properties.]]> http://www.bioworld.com/articles/728885 Mon, 16 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728885-stem-cell-derived-factor-has-potential-in-anti-nmdar-encephalitis Brain, syringe hovering over hands http://www.bioworld.com/articles/728788 Wed, 11 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728788-trx-319-silences-autoreactive-b-and-t-cells-in-multiple-sclerosis Illustration of lymphocytes http://www.bioworld.com/articles/728802 Tue, 10 Feb 2026 11:00:00 -0500 https://www.bioworld.com/articles/728802-vibrant-aims-to-tame-egfr-tumors-with-masked-tces T cells attacking cancer http://www.bioworld.com/articles/728647 Thu, 05 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728647-vibrant-aims-to-tame-egfr-tumors-with-masked-tces T cells attacking cancer http://www.bioworld.com/articles/728621 Tue, 03 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728621-astrazeneca-doubles-down-on-china-with-15b-investments Scientist at Astrazeneca China facility Research at an Astrazeneca China facility. Credit: Astrazeneca plc http://www.bioworld.com/articles/728597 Mon, 02 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728597-in-vivo-car-t-cells-reduce-liver-fibrosis Art concept for liver damage, such as fatty liver, fibrosis or cirrhosis http://www.bioworld.com/articles/728486 Fri, 30 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/728486-astrazeneca-doubles-down-on-china-with-15b-investments Scientist at Astrazeneca China facility Research at an Astrazeneca China facility. Credit: Astrazeneca plc http://www.bioworld.com/articles/728373 Tue, 27 Jan 2026 08:00:00 -0500 https://www.bioworld.com/articles/728373-in-vivo-car-t-cells-reduce-liver-fibrosis Art concept for liver damage, such as fatty liver, fibrosis or cirrhosis http://www.bioworld.com/articles/728016 Fri, 16 Jan 2026 07:00:00 -0500 https://www.bioworld.com/articles/728016-immunitybios-car-nk-shows-complete-responses-in-waldenstroms Natural killer cell attacking cancer cell